Piccolo Total Cholesterol Test System
Enzymatic Esterase--Oxidase, Cholesterol. 510(k) K023642, from Abaxis, Inc. (Union City, CA). Product code CHH, class 1.
As of Nov 18, 2026, K023642 is an FDA 510(k) held by Abaxis, Inc., substantially equivalent on Jan 24, 2003 after 86 days, with no recalls tied to it in FDA's recall database.
- Review time: 86 days
- Recalls: 0
- Cited as a predicate by: 2 devices
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFCholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein disorders. (PLESA DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Ames Sera-Pak Cholesterol Reagent KitK802743 · Miles Laboratories, Inc. · Dec 10, 1980
Cited as a predicate
2 later 510(k) summaries name this device as a predicate- LipidsK251091 · Truvian Health · Dec 30, 2025
- Piccolo Total Cholesterol - Capillary Test SystemK130200 · Abaxis, Inc. · Feb 15, 2013
Other CHH clearances
The newest 510(k)s for the same product code; their median review was 365 days; see every CHH device- LipidsK251091 · Truvian Health · Dec 30, 2025
- CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDESK232404 · Medicon Hellas S.A · Aug 9, 2024
- Cholesterol2K203597 · Abbott Ireland Diagnostics Division · Jun 30, 2022
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Oct 30, 2002
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1175
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files